HOME >> BIOLOGY >> NEWS
Engineered Neo-Organs For Bladder Replacement

In this research, the investigators created a new form of bladder in vitro, outside the living organism in the lab, and implanted it in 6 beagle dogs. For this study, a total of 14 beagles had a cystectomy. Two dogs underwent closure without a reconstructive procedure. Six beagles had bladder reconstruction with a cell-free biodegradable polymer. The third group of six dogs received reconstruction using a bladder-shaped biodegradable polymer that delivered autologous cells from the bladder epithelium, plus smooth muscle cells. The cells had been expanded separately from a previously harvested autologous bladder biopsy. The researchers performed preoperative and postoperative urinary flow and X-ray studies. After their initial operation and recovery, the animals were sacrificed at 1,2,3,4,6 and 11 months. The investigators performed gross pathology, along with histological and other analyses. Their results showed that in the tissue engineered replacement bladders, the average bladder capacity was 95% of the original pre- cystectomy volume. The polymer-only grafts were 46% of preoperative values, and the cystectomy-only controls were at 22%. The compliance of the tissue-engineered bladders (the quality of yielding to fluid pressure) showed almost no difference from pre-operative values. In their analysis, the investigators found that the retrieved tissue engineered bladders had normal cellular organization, consisting of a tri-layer of normal bladder epithelium, submucosa, and muscle. The investigators believe that tissue engineering can create functionally and anatomically normal bladders. They assert that this technology in the future could improve or even supplant conventional methods of bladder replacement or augmentation.


'"/>

Contact: Bill Glitz
wglitz@aol.com
703-532-3797
American Urological Association
31-May-1998


Page: 1

Related biology news :

1. Engineered virus provides impetus in search for HIV vaccine
2. Engineered proteins will lead to synthetic biology
3. Engineered mice point to new target for pain relief
4. Engineered Corn Can Kill Monarch Butterflies
5. Engineered Bacteria Scavenge Heavy Metals
6. Genetically Engineered Mice Exhibit Anxiety, Offering Insight Into Role Of Serotonin In Brain
7. Genetically Engineered Mice Show Characteristic Signs Of Alzheimers, Could Be Ideal Tool For Testing New Therapies
8. Body Building: Tissue Engineered Organs A Heartbeat Away
9. Jefferson Researchers First To Create Genetically Engineered Mouse To Study Photoaging
10. Two-Pronged Attack On Immune System Cells Engineered By HIV Gene vpr: Effects Markedly Reversed By Antisteroid Compound RU-486
11. Three-Way Gene-Gene-Environmental Exposure Interaction Shown By NIEHS To Escalate Smoking-Related Bladder Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Engineered Neo Organs For Bladder Replacement

(Date:8/4/2015)... Aug. 04, 2015 ... has announced the addition of the ... and Service), Sub-Segment (Computer Forensics, Network Forensics, ... Types, Service, Vertical and Region - Global ... offering. By Component (Hardware, Software, ...
(Date:8/4/2015)... Aug. 4, 2015  AMRI (NASDAQ: AMRI ) today reported ... 2015. Highlights: , Second quarter contract revenue ... 2014 , Adjusted contract margins of ... $0.22, including a $0.05 decrease in EPS from royalties in the ... million "We are very pleased to present another ...
(Date:8/3/2015)... SAN JOSE, Calif. , Aug. 3, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that members ... investment community at the Pacific Crest Global Technology Leadership ... Mountain Time. The conference will be held at the ... The presentation may include forward-looking information. ...
Breaking Biology News(10 mins):Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... bushing materials for pumps and process equipment, announces the appointment of Dennis Rawle ... the marine and industrial industries. Most recently, he was General Manager and Technical ...
(Date:8/4/2015)... According to a new ... Cardiac Biomarker - Market Opportunities, and Forecast, 2014-2020", ... revenue of $2,085.9 million by 2020, registering a ... Troponins (T, I) would continue to dominate the ... sensitivity and specificity.      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
(Date:8/4/2015)... , Aug. 4, 2015 Trigemina, Inc., ... of non-narcotic, nasally delivered, analgesic drug products, announced today ... to the position of chief medical officer. Dr. Kori ... Trigemina, much of which has been focused in the ... to add Dr. Kori to our clinical team given ...
(Date:8/4/2015)... ... August 04, 2015 , ... RPS ... tests – today announced that Robert A. Gregg, PhD, has joined RPS as ... 30 years of relevant experience and remarkable achievements in the medical device and ...
Breaking Biology Technology:Dennis Rawle Joins Graphite Metallizing Corporation 2Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 2Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 3Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 4Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 5Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 2Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 3RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 2RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 3
Cached News: